Forbes India - June 4, 2021

Bu konuda

The cover story in this edition is about Sputnik, the third vaccine to get the go-ahead from the Drug Controller of India for emergency use. At least five Indian pharma firms are on track to manufacture 852 million doses of the controversial Russian vaccine. The Hetero Group, for instance, has committed to manufacture 100 million doses. However, concerns around the effectiveness of Sputnik V and the single-dose Sputnik Light remain a cause of worry. Having said that, it is only expected to add to India’s vaccine armoury. That apart, this issue is also a ‘Sustainability Special’ and has stories on efforts across industries to make the planet greener.

Will Tech And Small Towns Give StanChart an Edge?

Unlike rival Citibank, standard Chartered bank has the option to explore retail banking more aggressively. backed by a digital thrust, Ceo Zarin daruwala has more opportunities than challenges ahead of her

7 mins

RUSSIAN GAMBIT

AMID CONCERNS SURROUNDING SPUTNIK V AND THE LAUNCH OF A SINGLE-DOSE VACCINE, INDIAN COMPANIES, INCLUDING HETERO, STELIS BIOPHARMA AND GLAND PHARMA ARE ON TRACK TO MAKE 900 MILLION DOSES OF SPUTNIK V IN A BID TO ALLEVIATE THE COUNTRY'S SUPPLY CONSTRAINTS

10+ mins

Message Delivered

How Beerud Sheth made Gupshup a profitable unicorn after one pivot, two near-death experiences and 15 years of slogging

7 mins

Industry 4.0: Climate Revolution?

Augmenting sustainability alongside digital capabilities is an economic, competitive and global opportunity for India’s businesses, but regulations need to reflect intent

10 mins

Flames of Destruction

Forest fires and their alerts in the country have gone up sharply in recent times, posing a serious threat to our environment, wildlife and biodiversity. Can wildfires be prevented in a world dealing with climate change?

8 mins

EV Dream Still Miles Away

Electric vehicles have remained a buzzword in India for years. But not much has moved on ground due to high upfront costs, range anxiety and charging infrastructure

6 mins

Living Waters

A virus has caused us to scramble for oxygen but our chokehold on the environment is slowly strangling the very waters that breathe life into us. The virus is a timely reminder: We are merely consumers, not producers of life’s breath on this planet

4 mins

Paytm 3.0 - Reaching Near Breakeven In Two Years

As of 2020, Vijay Shekhar Sharma’s super app for financial services had run up losses in thousands of crores. Now, as digital payments gets yet another boost courtesy Covid-19, he’s hopeful of reaching near breakeven in two years

10+ mins

Growth Story

After playing a central role in establishing Capgemini’s strong base in India and its global acquisition strategy, CEO Aiman Ezzat must now defend his turf from India’s IT giants

10+ mins

Aiming High

With growing investor interest, cannabis startups in India hope to become part of a global boom where industrial hemp is used in sectors ranging from medicines to textiles

10+ mins

Forbes India dergisindeki tüm hikayeleri okuyun

Forbes India Magazine Description:

Forbes is the world’s leading business magazine and since its inception in 1917, Forbes has stood, unwavering, for one overriding principle: the unshakable belief in the power of free enterprise.
Forbes mission has always been clear and unchanging: to provide insights and information that ensure the success of the world’s most influential. Faithfully fulfilling that promise is what draws today's most influential business leaders to Forbes. These high-powered decision-makers represent a community of like-minded individuals bound by their unshakable belief in the spirit of free enterprise. They contribute to it, profit from it and their lives are better for it. For them, Forbes is the quintessential Capitalist Tool.
True to its pedigree, Forbes India has donned on the role of the drama critic to Indian business. Since its launch in 2009, the magazine has helped readers connect the dots, form patterns and see beyond the obvious, giving them a perspective beyond the obvious.